Concepedia

Uwe Trefzer

UT

Statistics

Publications

61

Citations

9.5K

H-Index

37

Active since

1996

Affiliations

Charité - Universitätsmedizin Berlin(Current)

Heidelberg University

University Hospital Heidelberg

Humboldt-Universität zu Berlin

University Hospital of Zurich

Uwe Trefzer is an author at Charité - Universitätsmedizin Berlin specializing in oncology, medicine, and metastatic melanoma treatment.

Publications per year

1996–2019

61

Publications

61

Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group

Keith T. Flaherty, Caroline Robert, Peter Hersey et al. · Zurich Open Repository and Archive (University of Zurich) · 2012 · 1.3K citations

, , +15

The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma

Eliezer M. Van Allen, Nikhil Wagle, Antje Sucker et al. · Cancer Discovery · 2013 · 940 citations · Full text

, , +17

Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial

Georgina V. Long, Uwe Trefzer, Michael A. Davies et al. · The Lancet Oncology · 2012 · 908 citations

, , +12

Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma

Antoni Ribas, Richard Kefford, Margaret Marshall et al. · Journal of Clinical Oncology · 2013 · 815 citations · Full text

, , +15

Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group

Agop Y. Bedikian, Michael Millward, Hubert Pehamberger et al. · Journal of Clinical Oncology · 2006 · 597 citations

, , +14

1–5 of 61